These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 16714377

  • 1. Differential effects of the oxidized metabolites of oltipraz on the activation of CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 for GSTA2 gene induction.
    Ko MS, Lee SJ, Kim JW, Lim JW, Kim SG.
    Drug Metab Dispos; 2006 Aug; 34(8):1353-60. PubMed ID: 16714377
    [Abstract] [Full Text] [Related]

  • 2. Ceramide, an apoptotic rheostat, inhibits CCAAT/enhancer binding protein-beta and NF-E2-related factor-2 activation: the role in glutathione S-transferase A2 gene repression.
    Park IN, Cho IJ, Kim SG.
    Drug Metab Dispos; 2004 Sep; 32(9):893-7. PubMed ID: 15319326
    [Abstract] [Full Text] [Related]

  • 3. Role of hepatitis B virus X repression of C/EBPbeta activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression.
    Cho IJ, Ki SH, Brooks C, Kim SG.
    Xenobiotica; 2009 Feb; 39(2):182-92. PubMed ID: 19255944
    [Abstract] [Full Text] [Related]

  • 4. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ, Kim SG.
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [Abstract] [Full Text] [Related]

  • 5. Glucocorticoid receptor (GR)-associated SMRT binding to C/EBPbeta TAD and Nrf2 Neh4/5: role of SMRT recruited to GR in GSTA2 gene repression.
    Ki SH, Cho IJ, Choi DW, Kim SG.
    Mol Cell Biol; 2005 May; 25(10):4150-65. PubMed ID: 15870285
    [Abstract] [Full Text] [Related]

  • 6. Ceramide negatively regulates glutathione S-transferase gene transactivation via repression of hepatic nuclear factor-1 that is degraded by the ubiquitin proteasome system.
    Park IN, Cho IJ, Kim SG.
    Mol Pharmacol; 2004 Jun; 65(6):1475-84. PubMed ID: 15155840
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection.
    Kwon YN, Shin SM, Cho IJ, Kim SG.
    Drug Metab Dispos; 2009 Jun; 37(6):1187-97. PubMed ID: 19299524
    [Abstract] [Full Text] [Related]

  • 9. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY, Cho IJ, Kim SG.
    Cancer Res; 2004 May 15; 64(10):3701-13. PubMed ID: 15150131
    [Abstract] [Full Text] [Related]

  • 10. Oltipraz promotion of liver regeneration after partial hepatectomy: The role of PI3-kinase-dependent C/EBPbeta and cyclin E regulation.
    Cho IJ, Sung DK, Kang KW, Kim SG.
    Arch Pharm Res; 2009 Apr 15; 32(4):625-35. PubMed ID: 19407981
    [Abstract] [Full Text] [Related]

  • 11. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes.
    McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, Wolf CR, Cavin C, Hayes JD.
    Cancer Res; 2001 Apr 15; 61(8):3299-307. PubMed ID: 11309284
    [Abstract] [Full Text] [Related]

  • 12. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
    Bae EJ, Kim SG.
    Mol Pharmacol; 2005 Sep 15; 68(3):660-9. PubMed ID: 15961673
    [Abstract] [Full Text] [Related]

  • 13. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
    Vollrath V, Wielandt AM, Iruretagoyena M, Chianale J.
    Biochem J; 2006 May 01; 395(3):599-609. PubMed ID: 16426233
    [Abstract] [Full Text] [Related]

  • 14. Differential hepatic GSTA2 expression of arylalkyl isothiocyanates in vivo and in vitro: the molecular mechanism of gene induction by phenethyl isothiocyanate.
    Gum SI, Cho MK.
    Mol Nutr Food Res; 2013 Dec 01; 57(12):2223-32. PubMed ID: 24039128
    [Abstract] [Full Text] [Related]

  • 15. Antioxidant and mitochondrial protective effects of oxidized metabolites of oltipraz.
    Choi SH, Kim YM, Lee JM, Kim SG.
    Expert Opin Drug Metab Toxicol; 2010 Feb 01; 6(2):213-24. PubMed ID: 20095791
    [Abstract] [Full Text] [Related]

  • 16. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
    Higgins LG, Cavin C, Itoh K, Yamamoto M, Hayes JD.
    Toxicol Appl Pharmacol; 2008 Feb 01; 226(3):328-37. PubMed ID: 18028974
    [Abstract] [Full Text] [Related]

  • 17. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
    Noh K, Kim YM, Kim YW, Kim SG.
    Drug Metab Dispos; 2011 Aug 01; 39(8):1451-9. PubMed ID: 21596890
    [Abstract] [Full Text] [Related]

  • 18. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ, Clayton M, Halbherr T, Myers CB, Yao Ks.
    Clin Cancer Res; 1997 May 01; 3(5):783-91. PubMed ID: 9815750
    [Abstract] [Full Text] [Related]

  • 19. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
    Primiano T, Egner PA, Sutter TR, Kelloff GJ, Roebuck BD, Kensler TW.
    Cancer Res; 1995 Oct 01; 55(19):4319-24. PubMed ID: 7671242
    [Abstract] [Full Text] [Related]

  • 20. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone.
    Lamb JG, Franklin MR.
    J Biochem Mol Toxicol; 2002 Oct 01; 16(4):154-61. PubMed ID: 12242683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.